Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard antidepressant therapy

Major depressive disorder (MDD) is a prevalent and disabling psychiatric disease with rates of non-responsiveness to antidepressants ranging from 30–50%. Historically, the monoamine depletion hypothesis has dominated the view on the pathophysiology of depression. However, the lack of responsiveness...

Descripción completa

Detalles Bibliográficos
Autores principales: Kopschina Feltes, Paula, Doorduin, Janine, Klein, Hans C, Juárez-Orozco, Luis Eduardo, Dierckx, Rudi AJO, Moriguchi-Jeckel, Cristina M, de Vries, Erik FJ
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5606303/
https://www.ncbi.nlm.nih.gov/pubmed/28653857
http://dx.doi.org/10.1177/0269881117711708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5606303/
https://www.ncbi.nlm.nih.gov/pubmed/28653857
http://dx.doi.org/10.1177/0269881117711708

Ejemplares similares